Back to search

United Kingdom· GB-APID-16557811000001100

Mysoline 250mg tablets

A primidone product containing primidone, registered in United Kingdom by Mawdsley-Brooks & Company Ltd. The same ATC class is registered in 17 of our 19 countries.

ATC N03AA03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedMysoline 250mg tabletsATCN03AA03REGISTER NO.GB-APID-1655781100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Primidone is registered in 17 of 19 countries.

Countries holding a registration under ATC N03AA03 (primidone), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose

Primidone · ATC N03AA03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of primidone costs, country by country.

Normalised to the WHO defined daily dose (1.25 g), the median price runs from $0.86 in Italy to $2.61 in Switzerland — a ×3.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Primidone · price per daily dose (1.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.61
  • FR France$0.88
  • IT Italy$0.86
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Primidone
Manufacturer
Mawdsley-Brooks & Company Ltd
Country
United Kingdom (GB)
ATC code
N03AA03
ATC class
Primidone
Defined daily dose
1.25 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

424 interactions on record for primidone.

Graded by severity as the source publishes them — 129 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Primidone · interactions on record

424 records

  • 129 severe
  • 199 moderate
  • 8 minor
  • 53 info

Most severe, free to view

  • RolapitantA04AD14severe
  • NaloxegolA06AH03severe
  • NaldemedineA06AH05severe
  • EliglustatA16AX10severe

35 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Primidone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All primidone products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Mysoline
  • Belgium · Mysoline
  • Czechia · Liskantin
  • Germany · Liskantin, Liskantin Saft
  • Denmark · Primidon Afortas, Primidon Orifarm
  • Estonia · Liskantin
  • Spain · Mysoline
  • Finland · Primidon Afortas
  • France · Mysoline
  • Hungary · Sertan
  • Ireland · Mysoline
  • Italy · Mysoline
  • Luxembourg · Mysoline
  • Malta · Mysoline, Primidone Serb
  • Netherlands · Mysoline
  • Norway · Primidon Afortas
  • Poland · Mizodin
  • Portugal · Mysoline
  • Sweden · Primidon Afortas

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f57dddd3-b287-4360-8ab7-2c473a5ed3bd
GET /v1/drugs/f57dddd3-b287-4360-8ab7-2c473a5ed3bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "16557811000001100",
  "desc": "Mysoline 250mg tablets (Mawdsley-Brooks & Company Ltd)",
  "form": "Oral tablet",
  "vpid": "42135811000001101",
  "source": "dmd",
  "vtm_id": "777315005",
  "strength": "250 mg",
  "substance": "Primidone",
  "ingredient": "Primidone",
  "supplier_code": "15125811000001100"
}

See everything about primidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.